--- title: 6 Proven Strategies for Representative Trial Recruitment | Acclinate description: Discover 6 actionable strategies for representative trial recruitment that are grounded in community insight, affective trust, and predictive analytics. image: https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/6-Proven-Strategies-for-Representative-Trial-Recruitment.jpg --- [![Acclinate Logo](https://blog.acclinate.com/hs-fs/hubfs/Acclinate-logo.png?width=2000&height=497&name=Acclinate-logo.png "Acclinate Logo")](https://www.acclinate.com/) - Products - [NOWINCLUDED](https://www.acclinate.com/products/nowincluded-the-community) - [eDICT](https://www.acclinate.com/products/e-dict) - Solutions - [Pharmaceutical Companies](https://www.acclinate.com/solutions/for-pharmaceutical-companies) - [Contract Research Organizations](https://www.acclinate.com/solutions/for-cros) - [Partners](https://www.acclinate.com/solutions/community-partners) - Company - [About Us](https://www.acclinate.com/about) - [Careers](https://www.acclinate.com/careers) - [News](https://news.acclinate.com) - Resources - [Resource Library](https://www.acclinate.com/resources) - [Blog](https://blog.acclinate.com) - [Press Kit](https://www.acclinate.com/press-kit) - [Events](https://www.acclinate.com/events) - [Glossary](https://www.acclinate.com/glossary) - [FAQ](https://www.acclinate.com/faq) - [Talk to Our Team](https://info.acclinate.com/get-in-touch) [![Talk to Our Team](https://no-cache.hubspot.com/cta/default/19943632/2e1c34dc-aaa1-43b8-b5f4-469b0db4e302.png)](https://cta-redirect.hubspot.com/cta/redirect/19943632/2e1c34dc-aaa1-43b8-b5f4-469b0db4e302) [![Acclinate Logo](https://blog.acclinate.com/hs-fs/hubfs/Acclinate_Logo.png?width=500&height=149&name=Acclinate_Logo.png "Acclinate Logo")](https://www.acclinate.com/) - Products - [**NOWINCLUDED**Acclinate’s B2C community platform ](https://www.acclinate.com/products/nowincluded-the-community) - [**e-DICT**Acclinate’s patented AI-powered technology ](https://www.acclinate.com/products/e-dict) - Solutions - [**Pharmaceutical Companies**Community-driven recruitment and real-world insights to support diverse, compliant clinical trials. ](https://www.acclinate.com/solutions/for-pharmaceutical-companies) - [**Contract Research Organization (CRO)**Scalable patient engagement and recruitment solutions that reduce risk and improve enrollment timelines. ](https://www.acclinate.com/solutions/for-cros) - [**Partners**Trusted partnerships that connect research opportunities with the communities they aim to serve. ](https://www.acclinate.com/solutions/community-partners) - Company - [**About us**We help clinical research teams reach diverse communities, build trust, and improve trial participation. ](https://www.acclinate.com/about) - [**Careers**Join a mission-driven team advancing inclusive clinical research and community-powered health innovation. ](https://www.acclinate.com/careers) - Resources - [**Resources Hub** ](https://www.acclinate.com/resources) - [**Glossary** ](https://www.acclinate.com/glossary) - [**Press Kit** ](https://www.acclinate.com/press-kit) - [**Events** ](https://www.acclinate.com/events) - [**Blog** ](https://blog.acclinate.com/) - [**News** ](https://news.acclinate.com/) - [![](https://cdn.prod.website-files.com/695fbca039298e2117988a78/69e7b588548c7ad7bd8ab0bc_9dd915489696393dc63d7785ee2e52c7_Question%20mark%20image.png) **FAQs** ](https://www.acclinate.com/faq) - [ Contact Us ](https://www.acclinate.com/contact-us) Stay up to date Get news directly in your inbox Topic All - [Affective Trust ](https://blog.acclinate.com/tag/affective-trust) - [Announcement ](https://blog.acclinate.com/tag/announcement) - [Clinical Research Software ](https://blog.acclinate.com/tag/clinical-research-software) - [Clinical Trial Recruitment Strategies ](https://blog.acclinate.com/tag/clinical-trial-recruitment-strategies) - [Community ](https://blog.acclinate.com/tag/community) - [Diversity in Clinical Trials ](https://blog.acclinate.com/tag/diversity-in-clinical-trials) - [e-DICT™ ](https://blog.acclinate.com/tag/e-dict) - [FDA Diversity Plan ](https://blog.acclinate.com/tag/fda-diversity-plan) - [FDA Guidance: Diversity in Clinical Trials ](https://blog.acclinate.com/tag/fda-guidance-diversity-in-clinical-trials) - [Health Equity ](https://blog.acclinate.com/tag/health-equity) - [Partnerships ](https://blog.acclinate.com/tag/partnerships) - [Representation in Healthcare ](https://blog.acclinate.com/tag/representation-in-healthcare) [Clinical Trial Recruitment Strategies](https://blog.acclinate.com/topic/clinical-trial-recruitment-strategies) # 6 Proven Strategies for Representative Trial Recruitment Discover 6 actionable strategies for representative trial recruitment that are grounded in community insight, affective trust, and predictive analytics. ![6 Proven Strategies for Representative Trial Recruitment](https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/6-Proven-Strategies-for-Representative-Trial-Recruitment.jpg) Clinical Trial Diversity: What Does It Really Mean? Clinical trials are critical for evaluating the safety and effectiveness of medical devices and pharmaceutical products. The results of trials guide t... Read More ![ Acclinate](https://blog.acclinate.com/hubfs/69b96486c4b036c19f462c19_acclinate-logo.png) [Acclinate](https://blog.acclinate.com/author/acclinate) Acclinate turns trust and data into better representation. Share this Post: [**](https://www.facebook.com/sharer/sharer.php?u=https://blog.acclinate.com/6-proven-strategies-for-representative-trial-recruitment-acclinate) [**](https://twitter.com/home?status=https://blog.acclinate.com/6-proven-strategies-for-representative-trial-recruitment-acclinate) [** ](https://www.linkedin.com/shareArticle?mini=true&url=https://blog.acclinate.com/6-proven-strategies-for-representative-trial-recruitment-acclinate&title=6%20Proven%20Strategies%20for%20Representative%20Trial%20Recruitment%20|%20Acclinate) Stay up to date Get news directly in your inbox **Key Takeaways and Learnings**  - One-size-fits-all efforts don’t result in inclusive participant outreach plans that work.  - Predictive analytics, community platforms, and authentic local relationships make recruitment more precise, equitable, and effective.  - Affective trust and long-term partnerships are essential to overcoming enrollment disparities.  - **Download: **Learn more about ensuring representation and building trust in healthcare research. Read Acclinate’s [Ultimate Guide to Advancing Health Equity in Clinical Trials](https://info.acclinate.com/ebook-ultimate-guide-to-advancing-health-equity-in-clinical-trials).  Clinical research doesn’t always reflect the people it aims to serve. But it’s not for lack of trying: CROs, sponsors, recruitment firms, and others have all attempted to improve diversity in clinical trials. Nevertheless, communities of color remain underrepresented.   When clinical research fails to represent everyone affected, [sponsors risk](https://blog.acclinate.com/the-consequences-of-a-lack-of-diversity-in-clinical-trials) skewed data, increased costs, and delays getting life-changing therapies to those who need them. Trials close and critical treatments are kept out of reach.  Sponsors need more than good intentions or one-off tactics for overcoming enrollment disparities. They need *strategies* for representative trial recruitment.   These six strategies, built around data, trust, and long-term engagement, come directly from Acclinate’s work with sponsors, CROs, and communities.  ## **1. Build Representation Into Site Selection**  Inclusive participant outreach plans must begin at the protocol level. You can’t fix representation by tinkering with recruitment. It’s a design issue, which makes it a site selection issue.   Inclusive trials consider where sites are located and who’s on staff. Will a white principal investigator with an all-white team cultivate trust and confidence in communities of color? Maybe not. Research published in 2025 found that [Black respondents’ interest in clinical research participation increased](https://www.sciencedirect.com/science/article/pii/S0167629625000025) when shown a photograph of a Black investigator. The researchers point out that trustworthiness plays a major role in decisions to participate in clinical trials—or even to engage with the healthcare system.  [Other factors matter as well](https://blog.acclinate.com/clinical-trial-recruitment-strategies-that-increase-diversity), so strategies for representative trial recruitment must address several concerns. Can participants drive to the site easily? Is it close to mass transit? Will participants need childcare? Must the site accommodate family members or caregivers? Can a site schedule visits to accommodate shift workers or others with atypical schedules? The point is to reduce non-clinical barriers that keep people from enrolling—or drive them to drop out.  These obstacles won’t be the same for everyone, though. So how do you know which ones need to be removed for your particular study? Listen to the people you want to enroll.   **Discover the three steps organizations can take [to build relationships with communities of color](https://info.acclinate.com/3-steps-to-engage-communities-of-color). ** ## **2. Partner With Trusted Community Organizations**  Real engagement comes from real relationships. A recruitment flyer won’t convince people to enroll. Neither will a Facebook or radio ad. Conversations might. And those conversations take place in the community, so inclusive participant outreach plans must outline ways to integrate organically into people's everyday environments. That means showing up in spaces where trust already exists.  Local churches, barbershops, and community health centers aren’t just places. They are connection points. When sponsors build a steady, respectful presence in these spaces, people listen.   Acclinate collaborates with these community partners to co-create outreach strategies that are personal, not promotional.  Here’s one example: Acclinate built a “community circle” specifically for maternal and fetal health in its NOWINCLUDED platform, and it reached out to communities of color with [relevant content, resources, and experiences for maternal and fetal health](https://www.acclinate.com/acclinates-equitable-maternal-fetal-health-innovations-case-study). More than 18,000 platform members engaged with this material. Over 45% of them indicated they’d be willing to participate in clinical research.   ### Everyday Touchpoint: The Local Pharmacy  Pharmacies are among the most trusted and accessible places in the healthcare system. Acclinate saw an opportunity to put this trust into action and partnered with Good Neighbor Pharmacy, a network of independent pharmacies, to explore how they can serve as activation points for community-driven clinical research and aid in the mission of overcoming enrollment disparities.   A pilot study confirmed that pharmacies can be powerful partners in expanding clinical research participation and increasing representation. Pharmacists can be community ambassadors, helping foster trust and increase participation in research. Moreover, using pharmacies as recruitment sites can bridge the awareness-to-participation gap.  ## **3: Before You Recruit, Build Affective Trust **  You can’t cultivate trust overnight—and you definitely can’t build it the day you need someone to sign up. That’s why collaborating with communities is one of the most powerful strategies for representative trial recruitment.  Acclinate’s approach works because of something called *affective trust*, which relies on emotional connection and cultural empathy. Acclinate’s [Affective Trust Framework](https://blog.acclinate.com/clinical-trial-diversity-an-affective-trust-framework-for-engaging-recruiting-communities-of-color) prioritizes emotional connection over persuasion. It means listening before messaging, showing up without an agenda, and making people feel seen, not sold to.  Trust-building tactics in inclusive participant outreach plans don’t need to be high-tech. Sometimes, the most effective one is a phone call. Laquita Gilbert, Acclinate’s Director of Community Engagement, wrote about this in a recent blog post, [Beyond Efficiency: The Power of a Phone Call in Community-Based Health](https://blog.acclinate.com/beyond-efficiency-the-power-of-a-phone-call-in-community-based-health).  “This is what we mean when we talk about community-based health—meeting people where they are, not just geographically, but emotionally,” she says. “Familiarity builds comfort. Comfort builds trust. And trust opens the door for deeper conversations about health, wellness, and research participation.”  This doesn’t mean technology is unimportant. It’s essential, but Acclinate always uses technology in service of engagement.   ## **4: Use AI and Predictive Analytics to Guide Outreach**  Artificial intelligence (AI) can do more than identify the “right” participants. The most effective AI tools help sponsors and CROs uncover barriers to trial participation—such as geographic access, technology gaps, or previous engagement patterns.   Acclinate’s AI-powered solutions integrate predictive analytics with lived experience to make recruitment smarter and more equitable.  While many [AI models reinforce healthcare inequities](https://fas.org/publication/improving-health-equity-through-ai/) due to biased or incomplete datasets, Acclinate takes a different approach. Our tools are built by a diverse team and continuously refined through ongoing community insight, making them more accurate, relevant, and inclusive.  e-DICT helps identify both where participation is likely and what might stand in the way. It doesn’t replace human connection—it strengthens it.   e-DICT works in tandem with NOWINCLUDED, our health education and community engagement platform, to foster trust, insight, and long-term participation. Both are crucial solutions to consider when developing your strategies for representative trial recruitment.  ## **5: Use Community Platforms Like NOWINCLUDED**  Too many outreach efforts treat engagement like a transaction when it’s really a relationship.  NOWINCLUDED, Acclinate’s platform for ongoing education, storytelling, and health empowerment, is a space where people can share their experiences, learn about conditions that affect them, and find opportunities to participate in clinical research.  It’s a hub for connection that yields results. In one Alzheimer’s trial, our partnership helped pre-screen nearly four times more participants in four months than the sponsor had screened in the entire previous year.  NOWINCLUDED strengthens inclusion not through short-term campaigns, but by cultivating trust over time and across studies, which is essential for multi-phase or longitudinal trials. Together with e-DICT, it helps turn community connections into ongoing engagement.  ## **6: Personalize Messaging and Channels by Demographic Insight**  Mass emails and generic brochures don’t bring in trial participants—especially in communities that have been historically excluded. Tactics and strategies for representative trial recruitment must be personalized.  Outreach needs to speak the language of its audience, literally and metaphorically. That means tailoring not just what’s said, but how and where it’s said. That informs the message and the visuals we use, as well as the method of delivery. Text, social media, video, email, phone calls—the approach must be based on each community’s preferences, access, and habits.  Personalized campaigns spark interest and build trust in clinical research. That interest and trust lead to enrollment.   ## **Overcoming Enrollment Disparities****: Next Steps**  It’s time for a more sustainable approach to developing inclusive participant outreach plans. And these six strategies are important to incorporate for any CRO looking to not just reach inclusion goals, but to truly represent the communities they aim to help—in the short and long term.  Are you ready to put strategies for representative trial recruitment into action? [Schedule a 1:1 meeting with our team](https://www.acclinate.com/contact-us) to learn more.  [![Before You Recruit: The Ultimate Guide to Advancing Health Equity in Clinical Trials](https://no-cache.hubspot.com/cta/default/19943632/77a48b61-8ce6-44a3-b69b-3d080ed93db6.png)](https://cta-redirect.hubspot.com/cta/redirect/19943632/77a48b61-8ce6-44a3-b69b-3d080ed93db6)   ## Recent Posts [![Clinical Trial Management: The Hidden Risk of Homogeneous Trials in a One-Pivotal-Study World](https://blog.acclinate.com/hubfs/mature-female-patient-at-doctors-appointment-2026-01-08-06-10-47-utc.webp) ](https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world) [- [Diversity in Clinical Trials](https://blog.acclinate.com/news/tag/diversity-in-clinical-trials) ](https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world) [ Clinical Trial Management: The Hidden Risk of Homogeneous Trials in a One-Pivotal-Study World ](https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world) June 25, 2026 3 Min Read Drug development economics are changing. Sponsors are increasingly relying on a single pivotal trial to support approval. Though the goal of this appr... Read More [![Clinical Trial Generalizability: What Regulators Will Scrutinize Next](https://blog.acclinate.com/hubfs/woman-visiting-dermatologist-2026-01-08-22-23-31-utc.webp) ](https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next) [- [Diversity in Clinical Trials](https://blog.acclinate.com/news/tag/diversity-in-clinical-trials) ](https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next) [ Clinical Trial Generalizability: What Regulators Will Scrutinize Next ](https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next) June 25, 2026 3 Min Read For years, generalizability was framed as a methodological concern. Reviewers debated whether results could reasonably extend beyond a trial’s enrolle... Read More [![Site Engagement Index (SEI): Measuring What Actually Builds Trust](https://blog.acclinate.com/hubfs/computer-screen-trading-and-back-with-charts-hom-2026-01-09-09-28-19-utc.webp) ](https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust) [- [Clinical Research Software](https://blog.acclinate.com/news/tag/clinical-research-software) ](https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust) [ Site Engagement Index (SEI): Measuring What Actually Builds Trust ](https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust) June 25, 2026 3 Min Read Clinical research lacks anything but metrics. Enrollment targets, site activation timelines, and digital engagement rates are tracked closely across s... Read More [![](https://blog.acclinate.com/hubfs/Imported_Blog_Media/6567a9f90c0cf111067913e2_Merck%20Pop%20Up2.png) ](https://blog.acclinate.com/acclinate-collaborates-with-merck-to-increase-clinical-trial-diversity) [ Acclinate to support Merck's oncology clinical trials ](https://blog.acclinate.com/acclinate-collaborates-with-merck-to-increase-clinical-trial-diversity) June 24, 2026 1 Min Read Acclinate, an expert in health equity through inclusive research, is collaborating with Merck, known as MSD outside the United States and Canada, to h... Read More [![Why Trial Diversity Is Now a Risk Management Strategy](https://blog.acclinate.com/hubfs/Why-Trial-Diversity-Is-Now-a-Risk-Management-Strategy.jpg) ](https://blog.acclinate.com/why-trial-diversity-is-now-a-risk-management-strategy) [- [Diversity in Clinical Trials](https://blog.acclinate.com/news/tag/diversity-in-clinical-trials) ](https://blog.acclinate.com/why-trial-diversity-is-now-a-risk-management-strategy) [ The New Control Lever: Why Trial Diversity Is Now a Risk Management Strategy ](https://blog.acclinate.com/why-trial-diversity-is-now-a-risk-management-strategy) March 2, 2026 3 Min Read For years, conversations around trial diversity were framed as ethical or reputational concerns. That framing no longer reflects regulatory reality. Read More [![Acclinate’s NOWINCLUDED: Turning Community Insights Into Research Equity](https://blog.acclinate.com/hubfs/AdobeStock_470269560.webp) ](https://blog.acclinate.com/acclinates-nowincluded-turning-community-insights-into-research-equity) [- [Community](https://blog.acclinate.com/news/tag/community) ](https://blog.acclinate.com/acclinates-nowincluded-turning-community-insights-into-research-equity) [ Acclinate’s NOWINCLUDED: Turning Community Insights Into Research Equity ](https://blog.acclinate.com/acclinates-nowincluded-turning-community-insights-into-research-equity) February 16, 2026 3 Min Read Clinical research equity efforts originate with good intentions. But they often hit a roadblock in practice: communities are asked to participate in h... Read More [![How Acclinate’s e-DICT™ Technology Builds Real-Time Community Trust](https://blog.acclinate.com/hubfs/AdobeStock_1631551849.webp) ](https://blog.acclinate.com/how-acclinates-e-dict-technology-builds-real-time-community-trust) [- [Community](https://blog.acclinate.com/news/tag/community) ](https://blog.acclinate.com/how-acclinates-e-dict-technology-builds-real-time-community-trust) [ How Acclinate’s e-DICT™ Technology Builds Real-Time Community Trust ](https://blog.acclinate.com/how-acclinates-e-dict-technology-builds-real-time-community-trust) February 9, 2026 3 Min Read Reaching underrepresented communities in healthcare research has never been simple. Participation decisions are shaped by lived experience, historical... Read More [![Data-Driven Inclusion](https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/Acclinate-Data-Driven-Inclusion.jpg) ](https://blog.acclinate.com/data-driven-inclusion-predictive-analytics-for-trial-enrollment) [- [Clinical Research Software](https://blog.acclinate.com/news/tag/clinical-research-software) ](https://blog.acclinate.com/data-driven-inclusion-predictive-analytics-for-trial-enrollment) [ Data-Driven Inclusion: Predictive Analytics for Trial Enrollment ](https://blog.acclinate.com/data-driven-inclusion-predictive-analytics-for-trial-enrollment) February 2, 2026 2 Min Read Subpar enrollment remains one of the most common causes of trial delays. But sponsors often miss a key factor: underrepresentation. Lack of diversity ... Read More [![Exploring Diversity in Clinical Research With Acclinate](https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/Exploring-Diversity-in-Clinical-Research-With-Acclinate.jpg) ](https://blog.acclinate.com/exploring-diversity-in-clinical-research-with-acclinate) [- [Diversity in Clinical Trials](https://blog.acclinate.com/news/tag/diversity-in-clinical-trials) ](https://blog.acclinate.com/exploring-diversity-in-clinical-research-with-acclinate) [ Exploring Diversity in Clinical Research With Acclinate ](https://blog.acclinate.com/exploring-diversity-in-clinical-research-with-acclinate) January 26, 2026 3 Min Read Diversity in clinical research remains a widely discussed goal, yet progress has been uneven. Trials still grapple with subpar representation, limited... Read More [![Clinical Trial Management: The Hidden Risk of Homogeneous Trials in a One-Pivotal-Study World](https://blog.acclinate.com/hubfs/mature-female-patient-at-doctors-appointment-2026-01-08-06-10-47-utc.webp) June 25, 2026 Clinical Trial Management: The Hidden Risk of Homogeneous Trials in a One-Pivotal-Study World Read More ](https://blog.acclinate.com/clinical-trial-management-the-hidden-risk-of-homogeneous-trials-in-a-one-pivotal-study-world) [![Clinical Trial Generalizability: What Regulators Will Scrutinize Next](https://blog.acclinate.com/hubfs/woman-visiting-dermatologist-2026-01-08-22-23-31-utc.webp) June 25, 2026 Clinical Trial Generalizability: What Regulators Will Scrutinize Next Read More ](https://blog.acclinate.com/clinical-trial-generalizability-what-regulators-will-scrutinize-next) [![Site Engagement Index (SEI): Measuring What Actually Builds Trust](https://blog.acclinate.com/hubfs/computer-screen-trading-and-back-with-charts-hom-2026-01-09-09-28-19-utc.webp) June 25, 2026 Site Engagement Index (SEI): Measuring What Actually Builds Trust Read More ](https://blog.acclinate.com/site-engagement-index-sei-measuring-what-actually-builds-trust) ![Woman wearing Acclinate Shirt](https://blog.acclinate.com/hs-fs/hubfs/layer1_image.webp?width=1600&height=1068&name=layer1_image.webp) ![Medical Research Software e-DICT](https://blog.acclinate.com/hs-fs/hubfs/layer2_image.webp?width=885&height=885&name=layer2_image.webp) ![layer2.2_image](https://blog.acclinate.com/hs-fs/hubfs/layer2.2_image.webp?width=1505&height=1197&name=layer2.2_image.webp) ![layer3_image](https://blog.acclinate.com/hs-fs/hubfs/layer3_image.webp?width=1600&height=1067&name=layer3_image.webp) ## Ready to Measure Your True Impact? Partner with Acclinate to turn mission into measurable, data-driven action. [ Get Started ](https://www.acclinate.com/contact-us) [![Acclinate Logo Reversed](https://blog.acclinate.com/hs-fs/hubfs/footer_logo.png?width=1600&height=398&name=footer_logo.png "Acclinate Logo Reversed")](https://www.acclinate.com/) - Products - [NOWINCLUDED](https://www.acclinate.com/products/nowincluded-the-community) - [e-DICT](https://www.acclinate.com/products/e-dict) - Solutions - [Pharmaceutical Companies](https://www.acclinate.com/solutions/for-pharmaceutical-companies) - [CROs](https://www.acclinate.com/solutions/for-cros) - [Community Partners](https://www.acclinate.com/solutions/community-partners) - Resources - [Resources Hub](https://www.acclinate.com/resources) - [Glossary](https://www.acclinate.com/glossary) - [Press Kit](https://www.acclinate.com/press-kit) - [Events](https://www.acclinate.com/events) - [News](https://news.acclinate.com/) - [Blog](https://blog.acclinate.com/) - [FAQs](https://www.acclinate.com/faq) - Company - [About us](https://www.acclinate.com/about) - [Careers](https://www.acclinate.com/careers) - [Contact Us](https://www.acclinate.com/contact-us) - Follow Us - [** Linkedin](https://www.linkedin.com/company/acclinateinc/) - [Privacy Policy](https://www.acclinate.com/privacy) - [Terms of Service](https://www.acclinate.com/terms-of-use-acclinate) ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Acclinate", "url" : "https://blog.acclinate.com/author/acclinate" }, "dateModified" : "2026-05-19T17:05:43.243Z", "datePublished" : "2025-08-21T13:30:00.000Z", "headline" : "6 Proven Strategies for Representative Trial Recruitment | Acclinate", "image" : [ "https://blog.acclinate.com/hubfs/Acclinate/Blog%20Images/6-Proven-Strategies-for-Representative-Trial-Recruitment.jpg" ], "mainEntityOfPage" : { "@id" : "https://blog.acclinate.com/6-proven-strategies-for-representative-trial-recruitment-acclinate", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://blog.acclinate.com/hubfs/Acclinate-logo.png" }, "name" : "Acclinate" } } ```